FFC#21/2016

The use of virtual reality in the reduction of pain and anxiety during venipuncture in children with Cystic Fibrosis: a randomized controlled trial

FFC#21/2016

The use of virtual reality in the reduction of pain and anxiety during venipuncture in children with Cystic Fibrosis: a randomized controlled trial

PRINCIPAL INVESTIGATOR

Sofia Bisogni (Dipartimento di Scienze della Salute, Università degli Studi di Firenze)

RESEARCHERS

5

CATEGORY

AREA 5 Clinical and Epidemiological research

DURATION

1 year

GOAL

€ 15.000 €

RESULTS

The study enrolled a total of 21 patients, of whom 11 in the experimental group and 10 in the control group. Before the beginning of the procedure (a venipuncture for blood sample), behavioural distress did not appear to be different in the two groups (6.2 vs. 10.3), as well as the fear perceived by the child and anxiety. 30 seconds after the start of the VR (Virtual Reality) video, behavioural distress was significantly lower in the experimental group (0.1 vs. 8.9, p 0.018), as well as the pain expressed by the child (0.6 vs 4.1, p 0.013) and the pain perceived by the child evaluated by the parent (0.7 vs 3.44, p 0.018). This study supports the effectiveness of VR as a distraction technique in patients with FC who frequently have to face invasive procedures.

OTHER RESULTS

FFC #3/2024

Two molecules are effective in activating Heat Shock Proteins and enhancing the action of CFTR correctors with the F508del mutation in vitro.

FFC#5/2024

Some peptide nucleic acids (PNAs) re-sensitise Pseudomonas aeruginosa to the antibiotic meropenem in vitro and reduce its virulence.

FFC#1/2023

Tezacaftor, one of the components of Kaftrio, induces an accumulation of dihydroceramides both in vitro and in vivo in animal models